Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.
Published October 23, 2024 · Recall initiated: September 24, 2024
Summary
FDA records drug Class II recall D-0011-2025, published October 23, 2024 and initiated September 24, 2024. Recalling firm: VIONA PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: 2544 pumps; Lot: Lot #: T400512, Exp 02/28/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization
What to do
Voluntary: Firm initiated
Get an email if DAPSONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DAPSONE
- Manufacturer
- VIONA PHARMACEUTICALS INC
- Distributor
- NY
- Lot
- Lot #: T400512, Exp 02/28/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by:January 8, 2025
- FDADapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by:January 8, 2025
- FDADapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India,November 13, 2024
- FDACisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only,October 23, 2024
- FDAAtovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc.,October 23, 2024
- FDADuloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa PharmaceuticalOctober 23, 2024
Questions about this recall
Was Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. recalled?
Yes. FDA published recall D-0011-2025 on October 23, 2024. Reported hazard: Crystallization
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DAPSONE.